All Publications

Pages

1. • Speech

   • 

   Invited lecture: T cell-defined tumor antigens: perspectives for cancer vaccines

   Van den Eynde, Benoît[UCL] Guéguen, M. Mandruzzato, S. van der Bruggen, Pierre[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1998) XIIIth Congress of the European Association of Urology — Barcelona, Spain
2. • Speech

   • 

   Invited lecture: Tumor antigens recognized by T cells: perspectives for cancer vaccines

   Van den Eynde, Benoît[UCL] Chaux, Pascal[UCL] Morel, Sandra[UCL] van der Bruggen, Pierre[UCL] De Giovanni, G.[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1998) 13th Annual Society for Biological Therapy Meeting — Pittsburg, USA
3. • Speech

   • 

   Invited lecture: T cell-defined tumor antigens

   Van den Eynde, Benoît[UCL] Chaux, Pascal[UCL] van der Bruggen, Pierre[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1998) European Network of Immunology Institutes Conference, "Pathogenic and Protective T cell responses" — Ile des Embiez, France
4. • BookChapter

   • 

   Tumour antigens recognized by cytolytic T lymphocytes: perspectives for specific immunotherapy of bladder cancer and other genitourinary tumours

   Marchand, Marie[UCL] Chatzopoulos, C. Brasseur, Francis[UCL] Guéguen, M. Patard, J.-J. François, P. Van Cangh, Paul[UCL] Van den Eynde, Benoît[UCL] (1996) European Urology Update Series — [ISBN : 978-9-0797-5470-0]
5. • Speech

   • 

   Invited Lecture: "Tumour specific antigens: Perspectives for vaccination"

   Coulie, Pierre G.[UCL] van der Bruggen, Pierre[UCL] Van den Eynde, Benoît[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1997) —
6. • Speech

   • 

   Towards vaccination with tumor antigens

   Coulie, Pierre G.[UCL] van der Bruggen, Pierre[UCL] Van den Eynde, Benoît[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1998) —
7. • Journal article

   • 

   Expression of Mage Genes By Non-small-cell Lung Carcinomas

   Weynants, Patrick[UCL] Lethé, Bernard[UCL] Brasseur, Francis[UCL] Marchand, Marie[UCL] Boon-Falleur, Thierry[UCL] (1994) International Journal of Cancer — Vol. 56, no. 6, p. 826-829 (1994)
8. • BookChapter

   • 

   Towards vaccination with defined tumor antigens ?

   van der Bruggen, Pierre[UCL] Chaux, Pascal[UCL] Mandruzzato, Susanna[UCL] Van den Eynde, Benoît[UCL] Coulie, Pierre G.[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1999) Molecular Biology of Hematopoiesis. — [ISBN : 978-0-306-46136-1]
9. • Speech

   • 

   Invited lecture: The molecular nature of T-cell defined tumor antigens

   Van den Eynde, Benoît[UCL] Chaux, Pascal[UCL] Morel, Sandra[UCL] van der Bruggen, Pierre[UCL] De Giovanni, G.[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1998) The Robert Steel Foundation International Symposium — New York, USA
10. • Journal article

    • 

    Perspectives for immunization of HLA-A1 patients carrying a malignant-melanoma expressing gene MAGE-1

    Marchand, Marie[UCL] Brasseur, Francis[UCL] van der Bruggen, Pierre[UCL] Coulie, Pierre G.[UCL] Boon, Thierry[UCL] (1993) Dermatology — Vol. 186, no. 4, p. 278-280 (1993)
11. • Journal article

    • 

    Peptide-based cancer vaccines

    Machiels, Jean-Pascal[UCL] van Baren, Nicolas[UCL] Marchand, Marie[UCL] (2002) Seminars in Oncology — Vol. 29, no. 5, p. 494-502 (2002)
12. • Journal article

    • 

    Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen

    Coulie, Pierre G.[UCL] Karanikas, Vaios[UCL] Lurquin, Christophe[UCL] Colau, Didier[UCL] Connerotte, Thierry[UCL] Hanagiri, Takeshi[UCL] Van Pel, Aline[UCL] Lucas, Sophie[UCL] GODELAINE, Danièle[UCL] Lonchay, Christophe[UCL] Marchand, Marie[UCL] van Baren, Nicolas[UCL] Boon, Thierry[UCL] (2002) Immunological Reviews — Vol. 188, p. 33-42 (2002)
13. • Speech

    • 

    Invited lecture: Tumor antigens recognized by T lymphocytes

    Van den Eynde, Benoît[UCL] Guéguen, M. Mandruzzato, S. van der Bruggen, Pierre[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1997) 12th Meeting of the Society for Biological Therapy — Pasadena, USA
14. • Speech

    • 

    Invited lecture: T cell-defined tumor antigens: perspectives for cancer vaccines

    Van den Eynde, Benoît[UCL] Guéguen, M. Mandruzzato, S. van der Bruggen, Pierre[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1998) International Symposium on Recent Advances of Human Tumor Immunology and Immunotherapy — Sapporo, Japan
15. • Speech

    • 

    Invited Lecture: Achievements with immunotherapy of cancers.

    van Baren, Nicolas[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1999) Eurocancer 99 — Paris (France)
16. • Journal article

    • 

    Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA.

    Liénard, Danielle Rimoldi, Donata Marchand, Marie Dietrich, Pierre-Yves van Baren, Nicolas[UCL] Geldhof, Christine Batard, Pascal Guillaume, Philippe Ayyoub, Maha Pittet, Mikaël J Zippelius, Alfred Fleischhauer, Katharina Lejeune, Ferdy Cerottini, Jean-Charles Romero, Pedro Speiser, Daniel E (2004) Cancer Immunity — Vol. 4, p. 4 (2004)
17. • Journal article

    • 

    Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells

    van Baren, Nicolas[UCL] Bonnet, Marie-Claude Dréno, B. Khammari, A Dorval, T Piperno-Neumann, S Lienard, D. Speiser, David[UCL] Marchand, Marie[UCL] Brichard, Vincent G.[UCL] Escudier, B Negrier, S Dietrich, PY Maraninchi, D. Osanto, S Meyer, RG Ritter, G. Moingeon, P Tartaglia, J van der Bruggen, Pierre[UCL] Coulie, Pierre G.[UCL] Boon, Thierry[UCL] (2005) Journal of Clinical Oncology — Vol. 23, no. 35, p. 9008-9021 (2005)
18. • Journal article

    • 

    A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3

    Coulie, Pierre G.[UCL] Karanikas, Vaios Colau, Didier[UCL] Lurquin, Christophe Landry, Claire Marchand, Marie Dorval, Thierry Brichard, Vincent Boon-Falleur, Thierry[UCL] (2001) Proceedings of the National academy of sciences of the United States of America — Vol. 98, no. 18, p. 10290-10295 (2001)
19. • Journal article

    • 

    Immunologic analysis of a phase I/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors

    Vantomme, Valérie Dantinne, Christine Amrani, Noreddine Permanne, Philippe Gheysen, Dirk Bruck, Claudine Stoter, Gerrit Britten, Cedrik M Keilholz, Ulrich Lamers, Cor HJ Marchand, Marie[UCL] Delire, Marcel Gueguen, Maryse (2004) Journal Of Immunotherapy — Vol. 27, no. 2, p. 124-135 (2004)
20. • Journal article

    • 

    New vaccination approaches in melanoma with tumor antigens recognized by T lymphocytes.

    Marchand, Marie[UCL] van Baren, Nicolas[UCL] Raimundo, A.[UCL] Humblet, Yves[UCL] Tromme, Isabelle[UCL] (2002) Nederlands Tijdschrift voor Dermatologie en Venerologie — Vol. 12, p. 344-345 (2002)
21. • Speech

    • 

    Invited Lecture: Vaccination of melanoma patients with MAGE peptides.

    van Baren, Nicolas[UCL] Marchand, Marie[UCL] Weynants, Patrick[UCL] (1998) European Association for Cancer Research, XVth Meeting — Stockholm (Sweden)
22. • Journal article

    • 

    Monitoring of anti-vaccine CD4 T cell frequencies in melanoma patients vaccinated with a MAGE-3 protein

    Zhang, Yi[UCL] Sun, Zhaojun[UCL] Nicolay, Hugues[UCL] Meyer, Ralf G. Renkvist, Nicolina[UCL] Stroobant, Vincent[UCL] Corthals, Jurgen Carrasco Bertrand, Javier[UCL] Eggermont, Alexander Marchand, Marie[UCL] Thielemans, Kris Wolfel, Thomas Boon, Thierry[UCL] van der Bruggen, Pierre[UCL] (2005) Journal of Immunology — Vol. 174, no. 4, p. 2404-2411 (2005)
23. • Journal article

    • 

    A MAGE-3 peptide presented by HLA-DR1 to CD4(+) T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein

    Zhang, Y.[UCL] Chaux, P[UCL] Stroobant, Vincent[UCL] Eggermont, AMM Corthals, J Maillere, B Thielemans, K. Marchand, Marie[UCL] Boon, Thierry[UCL] van der Bruggen, Pierre[UCL] (2003) Journal of Immunology — Vol. 171, no. 1, p. 219-225 (2003)
24. • Journal article

    • 

    The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells.

    François, Violaine[UCL] Ottaviani, Sabrina[UCL] Renkvist, Nicolina Stockis, Julie[UCL] Schuler, Gerold Thielemans, Kris Colau, Didier Marchand, Marie Boon, Thierry[UCL] Lucas, Sophie[UCL] van der Bruggen, Pierre[UCL] (2009) Cancer Research — Vol. 69, no. 10, p. 4335-45 (2009)
25. • Speech

    • 

    Invited lecture: Tumor antigens recognized by cytolytic T lymphocytes

    Van den Eynde, Benoît[UCL] Guéguen, M. Mandruzzato, S. van der Bruggen, Pierre[UCL] Marchand, Marie[UCL] Coulie, Pierre G.[UCL] Boon, Thierry[UCL] (1997) 3rd European Conference on Gene Therapy of Cancer — Berlin, Germany

Pages